AMG
AMG
0.75 %
40.46 EUR
0.30
Quote
40.46
High
41.48
Change
0.75 %
Low
39.76
Updated
16:40:00
Open
40.02
News about AMG
Factsheet for AMG
Company Profile
Description
Bioporto A/S is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's segments include the NGAL Test, ELISA Human NGAL kits, ELISA Animal NGAL kits, ELISA MBL kits, Antibodies, and Other products and licenses. Bioporto generates majority of its revenues from Antibodies segment.
Key Stats
Website: http://www.bioporto.com
Headquarter country: Denmark
Employees: 25
Market Cap (at close 16/10/2018): DKK 608M
Fiscal Year Ends: December
Stats

Stats 2017 2016 2015 2014 2013
Price/Earnings 191.50 179.80
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -55.50 -45.80 -24.90 -29.00 -58.90
Return on Equity -64.30 -51.40 -29.30 -36.10 -98.90
Return on Invested Capital -63.90 -51.20 -28.80 -32.40 -62.10
Dividend


Dividend/Share:
Ex. Dividend Date:01/01/0001
Trailing Dividend Yield:
Payout Ratio:0.00
Date Currency Amount
Income Statement

Revenue 2017 2016 2015 2014 2013
Total Revenue 25.00 21.00 20.00 19.00 17.00
Gross Profit 0.020 0.020 0.020 0.010 0.010
Gross Margin % 72.54% 75.74% 75.95% 70.55% 54.39%
Operating Expenses 2017 2016 2015 2014 2013
EBITDA -37.00 -24.00 -12.00 -15.00 -20.00
Net income -32.00 -23.00 -11.00 -13.00 -21.00
Basic Earnings Per Share -0.220 -0.170 -0.090 -0.110 -0.260
Operating Income -0.040 -0.030 -0.010 -0.020 -0.020
Operating Margin % -145.08% -120.88% -62.60% -81.56% -119.11%
Cash Flow

Cash Flow 2017 2016 2015 2014 2013
Balance Sheet

Assets 31/12/2017 31/12/2016 31/12/2015 31/12/2014 31/12/2013
Current Assets 62,981 47,572 47,317 35,783 51,314
Long Term Assets 2,623.00 3,069.00 1,676.00 1,456.00 528.00
Total Assets 65,604 50,641 48,993 37,239 51,842
Liabilities 31/12/2017 31/12/2016 31/12/2015 31/12/2014 31/12/2013
Total Current Liabilities 8,653.00 5,146.00 4,444.00 8,466.00 8,875.00
Long Term Liabilities 883.00 1,204.00 64.00
Total Liabilities 9,536.00 6,350.00 4,508.00
Equity 31/12/2017 31/12/2016 31/12/2015 31/12/2014 31/12/2013
Retained Earnings -99,372 -97,890 -85,682 -89,836 -76,678
Treasury Stock 0.00 0.00 0.00 0.00 0.00
Total Stockholder Equity 56,068 44,291 44,485 28,686 42,862
Net Tangible Assets 54,439 42,332 43,926 28,487 42,862